Medical Writing Medical Writing in Oncology Journal Watch

Volume 21, Issue 1 - Medical Writing in Oncology

Journal Watch


Impact of protocol amendments, bias and quality in industry-funded trials, and rethinking authorship criteria

Amendments to clinical trial protocols are widespread, but can result in increased costs and delays in study implementation.


  1. Getz KA, Zuckerman R, Cropp AB, Hindle AL, Krauss R, Kaitin KI. Measuring the incidence, causes, and repercussions of protocol amendments. Drug Inf J 2011;45(03):265–75.
  2. Del Parigi A. Industry funded clinical trials: bias and quality. Curr Med Res Opin 2012;28(1):1–3.
  3. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003;290(7):921–8.
  4. Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond) 2008;32(10):1531–6.
  5. Golder S, Loke YK. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol 2008;66(6):767–73.
  6. Shaw D. The ICMJE's definition of authorship is illogical and unethical. BMJ 2011;343:bmj.d7192.
  7. Lippert S, Callaham ML, Lo B. Perceptions of conflict of interest disclosures among peer reviewers. PLoS One 2011;6(11):e26900.
  8. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. [cited 30 November 2011]. Available from:
  9. Callaham ML. Journal policy on ethics in scientific publication. Ann Emerg Med 2003;41(1):82–9.
  10. Annals of Emergency Medicine. Annals conflict of interest policy for editors and reviewers. [cited 1 December 2011]. Available from:
  11. Isaacs D. Conflict of interest: no such thing as a free lunch. J Paediatr Child Health 2011;47(10):679–80.



About the Medical Writing Journal
Oncology and medical writers
Message from the President
The war on cancer – What is the enemy, and are we winning?
Medical writing for cancer trials and submissions
Developing a treatment for ovarian cancer
The evolving landscape of medical education in oncology
Some considerations on the safety evaluation section of clinical study reports for studies with anticancer drugs
Identifying appropriate journals in which to publish original research on vaccines against human infectious diseases
New myths about English
From researcher in Europe to medical writer in India
Imaging techniques in oncology
Is cancer preventable? A literature review
A rising tide: Hospitals and social media
In the Bookstores
Journal Watch
The Webscout
Manuscript Writing
Regulatory Writing
Good Writing Practice
Out On Our Own
Translation Section

Member Login


The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board



Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: